malondialdehyde has been researched along with Pancreatic Insufficiency in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biasi, F; Bignamini, E; Calabrese, R; Lezo, A; Massarenti, P; Poli, G; Santini, B | 1 |
| Chełchowska, M; Laskowska-Klita, T; Narolewska, U; Nowaczewska, I | 1 |
2 other study(ies) available for malondialdehyde and Pancreatic Insufficiency
| Article | Year |
|---|---|
Oxidative stress in stable cystic fibrosis patients: do we need higher antioxidant plasma levels?
Topics: Aldehydes; Biomarkers; Child; Child, Preschool; Cysteine Proteinase Inhibitors; Cystic Fibrosis; Exocrine Pancreatic Insufficiency; Female; Fluorometry; Humans; Infant; Male; Malondialdehyde; Oxidative Stress; Reference Values | 2013 |
[Markers of oxidative damage in blood of children with cystic fibrosis].
Topics: Biomarkers; Blood Proteins; Child; Cystic Fibrosis; Diet Therapy; Exocrine Pancreatic Insufficiency; Female; Humans; Lipid Peroxides; Male; Malondialdehyde; Oxidative Stress; Poland; Risk Factors | 2002 |